# GlaxoSmithKline Biologicals SA – FDA Inspection, Jun 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/beae85df-4d31-45f7-93a5-448b49902f50
Source feed: FDA_Inspections

> FDA inspection 1099397 of GlaxoSmithKline Biologicals SA, June 24, 2019. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1099397
- Company Name: GlaxoSmithKline Biologicals SA
- Inspection Date: 2019-06-24
- Product Type: Biologics
- Center: Biologics
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1304664 - 2026-02-27](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/a737c389-4e6a-4fcc-94cb-27544c5ade52)
- FDA Inspection 1215345 - 2023-06-23
- [FDA Inspection 1007184 - 2017-01-27](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/70cb7ce5-0715-4ec4-8b61-c997bb03b824)
- FDA Inspection 900625 - 2014-10-02
- FDA Inspection 818683 - 2012-10-05

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/debra-m-emerson/58bd7fac-28eb-4369-b149-13a24cc00cf7)
- Issuing Officer
- [Issuing Officer](https://www.keypedia.com/people/shuang-tang/092f82be-f1d9-4c9d-a132-f1f653d47ead)
- [Issuing Officer](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)

Company: https://www.keypedia.com/companies/glaxosmithkline-biologicals-sa/ef569005-49c7-4bf9-b3f1-7814705bec8e

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8